The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome

Research output: Contribution to journalArticlepeer-review

Standard

The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome. / Oppong, Raymond; Jowett, Sue; Lewis, Martyn; Roddy, Edward; Ogollah, Reuben; Zwierska, Irena; Datta, Praveen ; Hall, Alison; Hay, Elaine; Shufflebotham, Julie ; Stevenson, Kay; van der Windt, Danielle A.; Young, Julie; Foster, Nadine.

In: Rheumatology, 07.01.2021.

Research output: Contribution to journalArticlepeer-review

Harvard

Oppong, R, Jowett, S, Lewis, M, Roddy, E, Ogollah, R, Zwierska, I, Datta, P, Hall, A, Hay, E, Shufflebotham, J, Stevenson, K, van der Windt, DA, Young, J & Foster, N 2021, 'The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome', Rheumatology. https://doi.org/10.1093/rheumatology/keaa903

APA

Oppong, R., Jowett, S., Lewis, M., Roddy, E., Ogollah, R., Zwierska, I., Datta, P., Hall, A., Hay, E., Shufflebotham, J., Stevenson, K., van der Windt, D. A., Young, J., & Foster, N. (2021). The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome. Rheumatology, [keaa903]. https://doi.org/10.1093/rheumatology/keaa903

Vancouver

Author

Oppong, Raymond ; Jowett, Sue ; Lewis, Martyn ; Roddy, Edward ; Ogollah, Reuben ; Zwierska, Irena ; Datta, Praveen ; Hall, Alison ; Hay, Elaine ; Shufflebotham, Julie ; Stevenson, Kay ; van der Windt, Danielle A. ; Young, Julie ; Foster, Nadine. / The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome. In: Rheumatology. 2021.

Bibtex

@article{e3902346f9f148b2be98fd396fb84da0,
title = "The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome",
abstract = "ObjectivesTo determine whether physiotherapist-led exercise intervention and US-guided subacromial CS injection is cost-effective when compared with standard advice and exercise leaflet and unguided injection in patients with subacromial pain (impingement) syndrome.MethodsAn incremental cost–utility analysis using patient responses to the five-level EuroQoL-5D (EQ-5D-5L) questionnaire was undertaken from a healthcare perspective alongside a 2 × 2 factorial randomized trial with 256 participants over a 12-month follow-up period. Uncertainty was explored through the use of cost-effectiveness acceptability curves.ResultsThe cost–utility analysis indicated that physiotherapist-led exercise was associated with an incremental cost of £155.99 (95% CI 69.02, 241.93) and 0.031 (95% CI −0.01, 0.07) additional quality-adjusted life-years (QALYs), an incremental cost-effectiveness ratio (ICER) of £5031 per QALY gained and an 85% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with the advice and exercise leaflet. US-guided injection was associated with an incremental cost of £15.89 (95% CI −59.36, 109.86) and 0.024 (95% CI −0.02, 0.07) additional QALYs, an ICER of £662 per QALY gained and a 83% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with unguided injection.ConclusionPhysiotherapist-led exercise was cost-effective compared with the advice and exercise leaflet, and US-guided injection was cost-effective when compared with unguided injection.Clinical trial registrationISRCTN, http://www.isrctn.com, ISRCTN42399123",
author = "Raymond Oppong and Sue Jowett and Martyn Lewis and Edward Roddy and Reuben Ogollah and Irena Zwierska and Praveen Datta and Alison Hall and Elaine Hay and Julie Shufflebotham and Kay Stevenson and {van der Windt}, {Danielle A.} and Julie Young and Nadine Foster",
year = "2021",
month = jan,
day = "7",
doi = "10.1093/rheumatology/keaa903",
language = "English",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",

}

RIS

TY - JOUR

T1 - The cost-effectiveness of different approaches to exercise and corticosteroid injection for subacromial pain (impingement) syndrome

AU - Oppong, Raymond

AU - Jowett, Sue

AU - Lewis, Martyn

AU - Roddy, Edward

AU - Ogollah, Reuben

AU - Zwierska, Irena

AU - Datta, Praveen

AU - Hall, Alison

AU - Hay, Elaine

AU - Shufflebotham, Julie

AU - Stevenson, Kay

AU - van der Windt, Danielle A.

AU - Young, Julie

AU - Foster, Nadine

PY - 2021/1/7

Y1 - 2021/1/7

N2 - ObjectivesTo determine whether physiotherapist-led exercise intervention and US-guided subacromial CS injection is cost-effective when compared with standard advice and exercise leaflet and unguided injection in patients with subacromial pain (impingement) syndrome.MethodsAn incremental cost–utility analysis using patient responses to the five-level EuroQoL-5D (EQ-5D-5L) questionnaire was undertaken from a healthcare perspective alongside a 2 × 2 factorial randomized trial with 256 participants over a 12-month follow-up period. Uncertainty was explored through the use of cost-effectiveness acceptability curves.ResultsThe cost–utility analysis indicated that physiotherapist-led exercise was associated with an incremental cost of £155.99 (95% CI 69.02, 241.93) and 0.031 (95% CI −0.01, 0.07) additional quality-adjusted life-years (QALYs), an incremental cost-effectiveness ratio (ICER) of £5031 per QALY gained and an 85% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with the advice and exercise leaflet. US-guided injection was associated with an incremental cost of £15.89 (95% CI −59.36, 109.86) and 0.024 (95% CI −0.02, 0.07) additional QALYs, an ICER of £662 per QALY gained and a 83% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with unguided injection.ConclusionPhysiotherapist-led exercise was cost-effective compared with the advice and exercise leaflet, and US-guided injection was cost-effective when compared with unguided injection.Clinical trial registrationISRCTN, http://www.isrctn.com, ISRCTN42399123

AB - ObjectivesTo determine whether physiotherapist-led exercise intervention and US-guided subacromial CS injection is cost-effective when compared with standard advice and exercise leaflet and unguided injection in patients with subacromial pain (impingement) syndrome.MethodsAn incremental cost–utility analysis using patient responses to the five-level EuroQoL-5D (EQ-5D-5L) questionnaire was undertaken from a healthcare perspective alongside a 2 × 2 factorial randomized trial with 256 participants over a 12-month follow-up period. Uncertainty was explored through the use of cost-effectiveness acceptability curves.ResultsThe cost–utility analysis indicated that physiotherapist-led exercise was associated with an incremental cost of £155.99 (95% CI 69.02, 241.93) and 0.031 (95% CI −0.01, 0.07) additional quality-adjusted life-years (QALYs), an incremental cost-effectiveness ratio (ICER) of £5031 per QALY gained and an 85% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with the advice and exercise leaflet. US-guided injection was associated with an incremental cost of £15.89 (95% CI −59.36, 109.86) and 0.024 (95% CI −0.02, 0.07) additional QALYs, an ICER of £662 per QALY gained and a 83% chance of being cost-effective at a threshold of £20 000 per QALY gained compared with unguided injection.ConclusionPhysiotherapist-led exercise was cost-effective compared with the advice and exercise leaflet, and US-guided injection was cost-effective when compared with unguided injection.Clinical trial registrationISRCTN, http://www.isrctn.com, ISRCTN42399123

U2 - 10.1093/rheumatology/keaa903

DO - 10.1093/rheumatology/keaa903

M3 - Article

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

M1 - keaa903

ER -